DF(Oat Bran) Intervention on Inflammation, Intestinal Flora, Disease Activity and Quality of Life in Patients With RA - Trial NCT06322784
Access comprehensive clinical trial information for NCT06322784 through Pure Global AI's free database. This phase not specified trial is sponsored by Shenzhen People's Hospital and is currently Completed. The study focuses on Rheumatoid Arthritis. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shenzhen People's Hospital
Timeline & Enrollment
N/A
Nov 01, 2022
Feb 10, 2024
Primary Outcome
Disease activity score,Quality of life score
Summary
The goal of this clinical trial is to test in Rheumatoid arthritis. The main question it aims
 to answer are:
 
 - To verify the effect of dietary fiber supplementation on reducing the level of
 inflammation;
 
 - To verify the effect of dietary fiber supplementation on improving disease activity and
 quality of life in patients with rheumatoid arthritis .To verify the effect of dietary
 fiber supplementation on regulating the production of anti-inflammatory short-chain
 fatty acid in the gut of patients with rheumatoid arthritis.
 
 The experimental group was supplemented with dietary fiber for 12 weeks, and the control
 group was fed with the Mediterranean diet. Before and after the intervention, 1 tube of 3ml
 blood and 1 soybean-sized stool were taken and a questionnaire was made
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06322784
Non-Device Trial